Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Neovasc Inc. (NVCN : NSDQ)
 
 • Company Description   
Neovasc Inc. is a specialty medical device company. It develops, manufactures and markets products for the cardiovascular marketplace. The Company's products include the Tiara (TM) mitral valve prosthesis in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer (TM) for the treatment of refractory angina and a line of advanced biological tissue products that are used as key components in third-party medical products, including transcatheter heart valves. Neovasc Inc. is headquartered in Richmond, Canada.

Number of Employees: 54

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.53 Daily Weekly Monthly
20 Day Moving Average: 27,029 shares
Shares Outstanding: 2.71 (millions)
Market Capitalization: $14.97 (millions)
Beta: 2.48
52 Week High: $28.25
52 Week Low: $4.64
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -41.79% -34.44%
12 Week -48.68% -43.58%
Year To Date -52.80% -38.15%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Suite 5138 - 13562 Maycrest Way
-
RICHMOND,A1 V6V 2J7
CAN
ph: 604-248-4138
fax: 604-270-4384
investors@neovasc.com http://www.neovasc.com
 
 • General Corporate Information   
Officers
Fred Colen - President and Chief Executive Officer
Steven Rubin - Chairman and Director
Chris Clark - Chief Financial Officer and Secretary
Bill Little - Chief Operating Officer
Alexei Marko - Director

Peer Information
Neovasc Inc. (ABMD)
Neovasc Inc. (DMDS)
Neovasc Inc. (CPWY.)
Neovasc Inc. (EQUR)
Neovasc Inc. (ECIA)
Neovasc Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 64065J403
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/09/22
Share - Related Items
Shares Outstanding: 2.71
Most Recent Split Date: 4.00 (0.04:1)
Beta: 2.48
Market Capitalization: $14.97 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-1.25 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-5.00 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.34
Price/Cash Flow: -
Price / Sales: 5.53
EPS Growth
vs. Year Ago Period: -201.00%
vs. Previous Quarter: -33.78%
Sales Growth
vs. Year Ago Period: 35.18%
vs. Previous Quarter: -19.50%
ROE
03/31/22 - -50.69
12/31/21 - -35.09
09/30/21 - -40.59
ROA
03/31/22 - -39.37
12/31/21 - -27.79
09/30/21 - -30.28
Current Ratio
03/31/22 - 12.88
12/31/21 - 11.08
09/30/21 - 11.16
Quick Ratio
03/31/22 - 12.50
12/31/21 - 10.79
09/30/21 - 10.86
Operating Margin
03/31/22 - -1,016.37
12/31/21 - -844.44
09/30/21 - -859.17
Net Margin
03/31/22 - -1,192.20
12/31/21 - -952.85
09/30/21 - -979.15
Pre-Tax Margin
03/31/22 - -1,211.86
12/31/21 - -973.77
09/30/21 - -1,029.76
Book Value
03/31/22 - 16.17
12/31/21 - 19.31
09/30/21 - 21.31
Inventory Turnover
03/31/22 - 0.42
12/31/21 - 0.41
09/30/21 - 0.37
Debt-to-Equity
03/31/22 - 0.27
12/31/21 - 0.16
09/30/21 - 0.14
Debt-to-Capital
03/31/22 - 21.56
12/31/21 - 13.77
09/30/21 - 12.34
 

Powered by Zacks Investment Research ©